{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T21:30:40Z","timestamp":1649194240916},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.lpm.2012.10.011","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T04:31:26Z","timestamp":1355113886000},"page":"93-101","source":"Crossref","is-referenced-by-count":1,"title":["Infections intestinales aigu\u00ebs\u00a0: vaccins actuels et futurs"],"prefix":"10.1016","volume":"42","author":[{"given":"Paul","family":"Erlich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe J.","family":"Sansonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2012.10.011_bib0005","doi-asserted-by":"crossref","first-page":"e29151","DOI":"10.1371\/journal.pone.0029151","article-title":"Estimating diarrhea mortality among young children in low and middle income countries","volume":"7","author":"Fischer Walker","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.lpm.2012.10.011_bib0010","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2471\/BLT.07.050054","article-title":"Estimating child mortality due to diarrhoea in developing countries","volume":"86","author":"Boschi-Pinto","year":"2008","journal-title":"Bull World Health Organization"},{"key":"10.1016\/j.lpm.2012.10.011_bib0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/erv.12.9","article-title":"Vaccines for enteric diseases: a meeting summary","volume":"11","author":"Steele","year":"2012","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.lpm.2012.10.011_bib0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2012.10.011_bib0025","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.lpm.2012.10.011_bib0030","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1086\/315462","article-title":"Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru","volume":"181","author":"Taylor","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2012.10.011_bib0035","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1586\/erv.09.137","article-title":"Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991\u20132009","volume":"8","author":"Chowdhury","year":"2009","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.lpm.2012.10.011_bib0040","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/IAI.70.4.1965-1970.2002","article-title":"Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine","volume":"70","author":"Cohen","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.lpm.2012.10.011_bib0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.vaccine.2006.08.031","article-title":"Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants","volume":"25","author":"Qadri","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2012.10.011_bib0050","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.vaccine.2007.08.027","article-title":"Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials","volume":"25","author":"Fraser","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.lpm.2012.10.011_bib0055","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2012.10.011_bib0060","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Mai","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.lpm.2012.10.011_bib0065","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"New Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2012.10.011_bib0070","first-page":"S20","article-title":"CVD 908, CVD 908-htrA, and CVD 909\u00a0live oral typhoid vaccines: a logical progression. Clinical infectious diseases","volume":"45","author":"Tacket","year":"2007","journal-title":"Infect Dis Soc Am"},{"key":"10.1016\/j.lpm.2012.10.011_bib0075","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","article-title":"Prevention of travellers\u2019 diarrhoea by oral B-subunit\/whole-cell cholera vaccine","volume":"338","author":"Peltola","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2012.10.011_bib0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1586\/erv.12.12","article-title":"Recent progress toward an enterotoxigenic Escherichia coli vaccine","volume":"11","author":"Svennerholm","year":"2012","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.lpm.2012.10.011_bib0085","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.vaccine.2010.10.035","article-title":"Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh","volume":"29","author":"Rahman","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2012.10.011_bib0090","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1016\/j.vaccine.2011.04.115","article-title":"Shigella sonnei vaccine candidates WRSs2\u00a0and WRSs3\u00a0are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection","volume":"29","author":"Barnoy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2012.10.011_bib0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clim.2011.02.003","article-title":"Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates","volume":"139","author":"Simon","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.lpm.2012.10.011_bib0100","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.vaccine.2005.07.014","article-title":"Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial","volume":"24","author":"McKenzie","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2012.10.011_bib0105","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2011.07.033","article-title":"Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50\u00a0vaccine","volume":"29","author":"Riddle","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2012.10.011_bib0110","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.4049\/jimmunol.0803141","article-title":"A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection","volume":"182","author":"Phalipon","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2012.10.011_bib0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/CVI.05161-11","article-title":"Identification of immunogenic and virulence-associated Campylobacter jejuni proteins","volume":"19","author":"Nielsen","year":"2012","journal-title":"Clin Vacc Immunol: CVI"},{"key":"10.1016\/j.lpm.2012.10.011_bib0120","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1128\/IAI.01021-09","article-title":"Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans","volume":"78","author":"Tribble","year":"2010","journal-title":"Infection Immun"},{"key":"10.1016\/j.lpm.2012.10.011_bib0125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1586\/erv.09.21","article-title":"Update on Campylobacter jejuni vaccine development for preventing human campylobacteriosis","volume":"8","author":"Jagusztyn-Krynicka","year":"2009","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.lpm.2012.10.011_bib0130","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1586\/erv.11.152","article-title":"Rotarix(R): vaccine performance 6\u00a0years postlicensure","volume":"10","author":"O\u2019Ryan","year":"2011","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.lpm.2012.10.011_bib0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1542\/peds.2006-2058","article-title":"Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life","volume":"119","author":"Block","year":"2007","journal-title":"Pediatrics"},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2012.10.011_bib0140","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1086\/431498","article-title":"Development of candidate rotavirus vaccines derived from neonatal strains in India","volume":"192","author":"Glass","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2012.10.011_bib0145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1754.1997.tb01604.x","article-title":"Phase 1\u00a0trial of a candidate rotavirus vaccine (RV3) derived from a human neonate","volume":"33","author":"Barnes","year":"1997","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.lpm.2012.10.011_bib0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/600104","article-title":"A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial","volume":"200","author":"Bhandari","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2012.10.011_bib0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/erv.09.163","article-title":"Norwalk virus-like particles as vaccines","volume":"9","author":"Herbst-Kralovetz","year":"2010","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.lpm.2012.10.011_bib0160","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"New Engl J Med"},{"key":"10.1016\/j.lpm.2012.10.011_bib0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2217\/fmb.09.115","article-title":"Challenges and prospects for a Cryptosporidium vaccine","volume":"5","author":"Mead","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.lpm.2012.10.011_bib0170","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.vaccine.2012.02.066","article-title":"Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.)","volume":"30","author":"Abd Alla","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2012.10.011_bib0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MOG.0b013e328333f8ee","article-title":"New and candidate vaccines for gastrointestinal infections","volume":"26","author":"Simon","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.lpm.2012.10.011_bib0180","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni0910-769","article-title":"Improving the performance of enteric vaccines in the developing world","volume":"11","author":"Serazin","year":"2010","journal-title":"Nature Immunol"},{"key":"10.1016\/j.lpm.2012.10.011_bib0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunoll Rev"},{"key":"10.1016\/j.lpm.2012.10.011_bib0190","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/IAI.73.5.3018-3024.2005","article-title":"The vaccine candidate Vibrio cholerae 638\u00a0is protective against cholera in healthy volunteers","volume":"73","author":"Garcia","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.lpm.2012.10.011_bib0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jfma.2011.09.024","article-title":"Rotavirus infection and the current status of rotavirus vaccines","volume":"111","author":"Chen","year":"2012","journal-title":"J Formosan Med Assoc=Taiwan yi zhi"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498212006124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498212006124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T05:30:07Z","timestamp":1540013407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498212006124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0755498212006124"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2012.10.011","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}